Neuronetics Inc 's (STIM) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Neuronetics Inc   (NASDAQ: STIM)
 



  Neuronetics Inc Outlook

On November 12 2024 the Neuronetics Inc provided following guidance

nnNeuronetics Inc. Reports Impressive Financial and Operational Performance in Third Quarter 2024nn

nnMALVERN, Pa., November 12, 2024nn – In a recently issued press release concerning its third-quarter results, Neuronetics, Inc. (NASDAQ: STIM) disclosed substantial advancements in both its financial and operational metrics. Importantly, the company’s updated financial guidance indicates that it anticipates reaching cash flow breakeven by the third quarter of 2025.

It is key to note a correction from the earlier announcement regarding the expectations set forth for achieving cash flow breakeven. Specifically, in the section discussing the stockholders' approval for the acquisition of Greenbrook TMS, the initial message suggested that this financial milestone was expected in the second quarter of 2025. This has now been amended, and the accurate projection is for the third quarter of 2025.

The comprehensive results reflect Neuronetics' steady progress and robust strategies, placing it on a promising trajectory toward sustainable financial health. Details reflecting these developments can be found in the full corrected release below.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.